Monumental Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$937K Sell
1,515
-244
-14% -$144K 0.35% 34
2024
Q2
$973K Sell
1,759
-382
-18% -$219K 0.42% 31
2024
Q1
$1.24M Sell
2,141
-55
-3% -$30.9K 0.66% 28
2023
Q4
$1.17M Buy
2,196
+96
+5% +$46.5K 0.7% 28
2023
Q3
$1.06M Buy
2,100
+133
+7% +$70.9K 0.71% 28
2023
Q2
$1.03M Sell
1,967
-16
-0.8% -$8.63K 0.69% 38
2023
Q1
$1.14M Buy
1,983
+165
+9% +$93K 0.82% 33
2022
Q4
$1M Buy
+1,818
New +$963K 0.81% 31

Other funds holding TMO

Monumental Financial Group's TMO Position: Q3 2024 in Review

Monumental Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q3 2024, selling an estimated $144K and leaving 1,515 shares worth $937K. The position accounts for 0.35% of the portfolio, ranked #34.

Monumental Financial Group first reported a position in TMO in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.24M in Q1 2024. 2,574 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Monumental Financial Group held 1,515 shares of Thermo Fisher Scientific worth $937K as of Q3 2024.
  • Monumental Financial Group sold 244 Thermo Fisher Scientific shares in Q3 2024, an estimated $144K.
  • Thermo Fisher Scientific made up 0.35% of Monumental Financial Group's portfolio in Q3 2024, its #34 holding.
  • Monumental Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 8 quarters since.
  • Monumental Financial Group's Thermo Fisher Scientific position peaked at $1.24M in Q1 2024.
  • 2,574 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Monumental Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.